Role of Cytochrome P450 2D6 (CYP2D6) *4 Polymorphism,in Malignant Breast Diseases

CompletedOBSERVATIONAL
Timeline

Start Date

January 31, 2006

Study Completion Date

April 30, 2007

Conditions
Breast Cancer
Interventions
GENETIC

pcr and serum markers for breast cancer

DNA extraction and genotyping of cytochrome P450-2D6\*4 gene using conventional PCR followed by restriction enzyme (Mva1) digestion. Separated plasma was used for measurement of plasma malondialdehyde(MDA)concentration, total plasma antioxidant capacity and plasma ferretin level.

Trial Locations (1)

35116

Mansoura Faculty of Medicine, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER

NCT00539422 - Role of Cytochrome P450 2D6 (CYP2D6) *4 Polymorphism,in Malignant Breast Diseases | Biotech Hunter | Biotech Hunter